Skip to main content
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp — Investor Relations & Filings

Ticker · UTHR ISIN · US91307C1027 LEI · 5299005C4HZL4UWROC14 US Manufacturing
Open in API
Filings indexed 2,877 across all filing types
Latest filing 2025-12-12 Director's Dealing
Country US United States of America
Listing US UTHR

About UNITED THERAPEUTICS Corp

https://www.unither.com/

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of therapies for chronic and life-threatening conditions. The company's primary therapeutic areas include pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also develops treatments for pediatric neuroblastoma. In addition to its pharmaceutical pipeline, United Therapeutics is actively engaged in research and development of technologies to manufacture transplantable organs and tissues, aiming to address the shortage of donor organs.

Recent filings

Filing Released Lang Actions
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document text primarily consists of detailed records of share transactions by Martine Rothblatt, who is identified as Founder, Chairperson, and CEO of United Therapeutics Corp. The text includes dates, number of shares, and transaction types related to executive deferred compensation and shares exercised via vested options. There is no indication of financial statements, earnings data, or management discussion. The content matches the description of a report of personal share transactions by company directors and executives, which corresponds to the Director's Dealing category. The document length is 6567 characters, sufficient to contain detailed transaction data rather than a brief announcement. Therefore, the appropriate classification is Director's Dealing (DIRS).
2025-12-12 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document text contains detailed records of share transactions by Martine Rothblatt, who is identified as Founder, Chairperson, and CEO. The text lists multiple dates, share quantities, and transaction values, indicating personal share dealings. There is no indication of financial results, report publication, or other corporate announcements. The presence of specific share transactions by a company director aligns with the definition of Director's Dealing filings, which report personal share transactions by company directors and executives. The document length is sufficient and the content is focused on insider trades rather than other report types or announcements.
2025-12-11 English
Regulatory Filings 2025
Regulatory Filings
2025-12-11 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-10 English
PRIMARY DOCUMENT
Director's Dealing
2025-12-10 English
Director's Dealing 2025
Director's Dealing Classification · 100% confidence The document text primarily consists of detailed records of share transactions by Martine Rothblatt, the founder, chairperson, and CEO of United Therapeutics Corp. It lists dates, share quantities, and transaction details related to shares exercised via vested options and payments made via common shares. There is no indication of financial statements, management discussion, earnings data, or other report content. The document is a report of personal share transactions by a company director, which fits the definition of Director's Dealing (DIRS). The document length is 6567 characters, sufficient to contain substantive data, and the content matches insider trading disclosures rather than other report types or announcements.
2025-12-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.